The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines
Abstract
Purpose: To determine whether an angiotensin-converting enzyme (ACE) inhibitor, enalapril, prevents cardiac function deterioration (defined using maximal cardiac index [MCI] on exercise testing or increase in left ventricular end-systolic wall stress [LVESWS]) in long-term survivors of pediatric cancer. Patients and Methods: This was a randomized, double-blind, controlled clinical trial comparing enalapril to placebo in 135 long-term survivors of pediatric cancer who had at least one cardiac abnormality identified at any time after anthracycline exposure. Results: There was no difference in the rate of change in MCI per year between enalapril and placebo groups (0.30 v 0.18 L/min/m 2; P = .55). However, during the first year of treatment, the rate of change in LVESWS was greater in the enalapril group than in the placebo group (−8.59 v 1.85 g/cm 2; P = .033) and this difference was maintained over the study period, resulting in a 9% reduction in estimated LVESWS by year 5 in the enalapril group. Six of seven patients removed from random assignment to treatment because of cardiac deterioration were initially treated with placebo (P = .11), and one has died as a result of heart failure. Side effects from enalapril included dizziness or hypotension (22% v 3% in the placebo group; P = .0003) and fatigue (10% v 0%; P = .013). Conclusion: Enalapril treatment did not influence exercise performance, but did reduce LVESWS in the first year; this reduction was maintained over the study period. Any theoretical benefits of LVESWS reduction in this anthracycline-exposed population must be weighed against potential side effects from ACE inhibitors when making treatment decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Ware, J. E., Kosinski, M. R., Bayliss, M. S., McHorney, C. A., Rogers, W. H., & Raczek, A. E. (1995) · PubMed · Cited by 1,735
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Self-citationAngiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
The modification of diet in renal disease study group
Beck, G. J., Berg, R. L., Coggins, C. H., Gassman, J. J., Hunsicker, L. G., Schluchter, M. D., & Williams, G. W. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90069-x · Cited by 818
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Colan, S. D., Borow, K. M., & Neumann, A. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80397-6 · Cited by 646
Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 552
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Landgraf, J. M., Maunsell, E., Nixon Speechley, K., Bullinger, M., Campbell, S., Abetz, L., & Ware, J. E. (1998) · Quality of Life Research · doi:10.1023/a:1008810004694 · Cited by 395
The impact of childhood cancer on the United States and the world
Bleyer, W. A. (1990) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.40.6.355 · Cited by 368
Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H. M., Schwartz, R. G., Shaffer, E. M., Sandor, G., Benson, L., & Williams, R. (1992) · Pediatrics · doi:10.1542/peds.89.5.942 · Cited by 327
Self-citationLipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Simbre, V. C., Shaikh, S. L., Mone, S. M., Gelber, R. D., & Colan, S. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.102 · Cited by 308
Shotan, A., Widerhorn, J., Hurst, A., & Elkayam, U. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90172-4 · Cited by 300
Colan, S. D., Parness, I. A., Spevak, P. J., & Sanders, S. P. (1992) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80282-7 · Cited by 285
Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults
Larsen, R. L., Jakacki, R. I., Vetter, V. L., Meadows, A. T., Silber, J. H., & Barber, G. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91393-i · Cited by 197
Self-citationCardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 Patients
Steinherz, L. J., Steinherz, P. G., & Tan, C. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240604 · Cited by 192
Self-citationAdverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
Kostis, J. B., Shelton, B. J., Gosselin, G., Goulet, C., Hood, W. B., Kohn, R. M., Kubo, S. H., SCHRON, E. B., Weiss, M. B., Willis, P. W., et al. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90365-8 · Cited by 158
Increased risk of cardiac dysfunction after anthracyclines in girls
Silber, J. H., Jakacki, R. I., Larsen, R. L., Goldwein, J. W., & Barber, G. (1993) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950210704 · Cited by 151
Self-citationLate effects of childhood cancer therapy
Friedman, D. L., & Meadows, A. T. (2002) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(02)00032-9 · Cited by 129
Cardiac function in Wilms' tumor survivors.
Sørensen, K. E., Levitt, G., Sebag‐Montefiore, D., Bull, C., & Sullivan, I. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1546 · Cited by 95
Patient-Based Health Status Measurements in Pediatric Dialysis: Expanding the Assessment of Outcome
Kurtin, P. S., Landgraf, J. M., & Abetz, L. N. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80205-8 · Cited by 79
Borow, K. M., Colan, S. D., & Neumann, A. (1985) · Circulation · doi:10.1161/01.cir.72.3.515 · Cited by 75
Angiotensin converting enzyme inhibitors in pregnancy
Mastrobattista, J. M. (1997) · Seminars in Perinatology · doi:10.1016/s0146-0005(97)80055-9 · Cited by 55
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J. R., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowsky, M., et al. (2001) · American Heart Journal · doi:10.1067/mhj.2001.118115 · Cited by 39
Self-citationLeft ventricular systolic and diastolic function after anthracycline chemotherapy in childhood
Iarussi, D., Galderisi, M., Ratti, G., Tedesco, M. A., Indolfi, P., Casale, F., Tullio, M. T. D., DIVITIIS, O. D., & Iacono, A. (2001) · Clinical Cardiology · doi:10.1002/clc.4960241006 · Cited by 36
Anthracycline-Induced Cardiotoxicity
Steinherz, L. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-10-199705150-00018 · Cited by 20
Self-citation
Cited by
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.07.012 · Cited by 1,795
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Metadata
- Authors
- Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M., Kimball, T. R., Delaat, C., Steinherz, L. J., & Zhao, H.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-03-01
- Volume
- 22
- Issue
- 5
- Pages
- 820-828
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2096949123
- Cited by
- 299
- References
- 36
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.